SEO URLwww.firestrike.ai/deals/eikon-therapeutics-merck-acquisition-2026

acquisitionAnnounced · Jan 29, 2026Professional, Scientific, and Technical Services (541)Source · CredibleArticle · Factual

Eikon Therapeutics · Merck

Merck acquires Eikon Therapeutics

David Najork · Founding Software Engineer

Announced Jan 29, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$30M

Target

Eikon Therapeutics

Hayward, California

Acquirer

Merck

Financial Stake

Status

Announced

Merck agreed to acquire Eikon Therapeutics. Reported deal value: $30M. Status: Announced. Sector: Not specified. Target headquarters context: Hayward, California, United States.

This page summarizes publicly available information about the transaction as of 2026-01-29. Figures and status may change as filings and press coverage update.

Merck Expected to Take $ 30 Million Stake in Eikon Therapeutics ' IPO Merck is expected to invest about $ 30 million for roughly 10% of shares in Eikon Therapeutics ' initial public offering , Bloomberg reported Thursday, citing people familiar with the matter. Eikon

Deal timeline

Announced

Jan 29, 2026 · in.marketscreener.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in Professional, Scientific, and Technical Services (541) with a reported deal value of $30M. Figures and status may change as sources update.

Sources: in.marketscreener.com · Primary article · FireStrike proprietary index